首页> 外文OA文献 >Characteristics of Patients With a Complete Response Treated With Dabrafenib + Trametinib Combination Therapy: Findings From Pooled COMBI-d and COMBI-v 5-Year Analysis

【2h】

Characteristics of Patients With a Complete Response Treated With Dabrafenib + Trametinib Combination Therapy: Findings From Pooled COMBI-d and COMBI-v 5-Year Analysis

机译：用DabrafeNib + Trametinib组合治疗治疗完整应答的患者的特征：汇集组合-D和Combi-V 5年分析的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Caroline Robert; Jean Grob; Daniil Stroyakovskiy; Boguslawa Karaszewska; Axel Hauschild; Evgeny Levchenko; Vanna Sileni; Jacob Schachter; Claus Garbe; Igor Bondarenko; Paul Nathan; Antoni Ribas; Michael Davies; Keith Flaherty; Paul Burgess; Monique Tan; Eduard Gasal; Dirk Schadendorf; Georgina Long;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial [J] . Grob Jean Jacques, Amonkar Mayur M., Karaszewska Boguslawa, The lancet oncology . 2015,第13期

机译：达拉非尼和曲美替尼联合疗法与维拉非尼单一疗法对无法切除或转移性皮肤BRAF Val600突变阳性黑色素瘤（COMBI-v）患者健康相关生活质量的比较：一项三阶段，开放标签，随机试验
2. Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials [J] . Long Georgina V., Grob Jean-Jacques, Nathan Paul, The lancet oncology . 2016,第12期

机译：达拉非尼和曲美替尼联合治疗后可预测反应，疾病进展和总体生存的因素：来自随机试验的单个患者数据的汇总分析
3. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials [J] . Schadendorf Dirk, Long Georgina V., Stroiakovski Daniil, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：三年合并分析与DabrafeNib和Trametinib组合治疗相3随机试验的临床结果相关的因素分析
4. Results of treatment in patients with IIa - IIIast. breast cancer treated by combination of low-level laser therapy (LLLT) and surgery (5-year experience) [C] . V.A. Mikhailov, Ctr. of Laser Medicine, Moscow, CIS Selected Papers: Laser Use in Oncology . 1996

机译：IIa-IIIast患者的治疗结果。低水平激光疗法（LLLT）和手术相结合治疗乳腺癌（5年经验）
5. Characteristics and optimal combination pharmacotherapy for newly-treated patients with diabetic painful neuropathy. [D] . Kuo, Kuan-Ling. 2015

机译：新近治疗的糖尿病性疼痛神经病患者的特征和最佳联合药物治疗。
6. Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy [O] . Haihua Peng, Chengtao Wang, Weiwei Xiao, 2018

机译：新辅助放化疗治疗局部晚期直肠癌的临床特征分析以预测病理完全缓解
7. Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy [O] . Haihua Peng, Chengtao Wang, Weiwei Xiao, 2018

机译：Neoadjuvant ChemoRAdiotapy治疗局部晚期直肠癌患者病理完全反应的临床特征分析

Characteristics of Patients With a Complete Response Treated With Dabrafenib + Trametinib Combination Therapy: Findings From Pooled COMBI-d and COMBI-v 5-Year Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅